Sinphar Pharmaceutical Co. Ltd. · TWSE:1734
Sinphar Pharmaceutical — 2025 Sinphar Pharmaceutical Investor Conference
34 slides from Sinphar Pharmaceutical's conference presentation, Dec 26, 2025
Slide 1: Sinphar Pharmaceutical 2025 Investor Conference
SINPHAR PHARMACEUTICAL CO., LTD. 2025 Investor Conference General Manager: Yu Liang Pei Chief Financial Officer: Chih Hsiao Chen December 26, 2025 1
Slide 2: Disclaimer
Disclaimer 本簡報是建立於本公司從各項來源所取得之資訊。有些 訊可能受未來不確定性因素影響，致使與原先本公司對 於未來前景的說明迥異。未來若有變更或調整時，請以 公開資訊觀測站公告資訊為依據。 所涉產業為法規高度規範與高度專業領域，提醒投資人 須審慎投資。 This presentation is based on the information obtained from various sources which the Company believes to be reliable. But at some point in the future, there ar
Slide 3: Contents
Contents 1. Operations Development 2. Financial Reports 3. Sustainable Development 3
Slide 4: From Taiwan to the World
From Taiwan to the World 2000 Sinphar TPEx-listed 2002 Sinphar TWSE-listed 2014 SynCoreBio TPEx-listed 1977 2002 2012 Established Sinphar Invested in Sinphar TianLi & Merged ZuniMed Ilan, Taiwan He-Tian Tianli Biotech Generic drugs, functional food, Hangzhou (CN), Xinjiang(CN) Nantou, Taiwan cosmeti
Slide 5: Integration
Stride Ahead According to TFDA and DCB data: 1. API manufacturer: 30 Integration Supplier 2. Western medicine Exporting to over 10 manufacturer:150 countries/regions and increasing. 3. Pharmaceutical/medicinal related companies: over 100 4. Medical device companies: over 10,000 International Collabo
Slide 6: Talent Management
Talent Management 1. Hard assets: Bronze prize winning TTQS approved vocational training center 2. Intangible assets: utilize Talent Management System (TMS) to track and learning and professional development. 3. From January to November 2025, TMS recorded an average monthly use of 119 employees, mon
Slide 7: Comprehensive health promotion
Comprehensive health promotion Drugs Recovery New Product Released in 2024: 2 New Product Released in 2025: 1 New Product Registration in 2026: 5 Staying Healthy Youthfulness Functional Supplements Medical Cosmetology Products New Product Released in 2025: 5 New Product Released in 2025: 8 New Produ
Slide 8: Comprehensive Product Line for All Ages
Comprehensive Product Line for All Ages Dermatology Ophthalmology Pediatrics Oncology Otolaryngology Orthopedics Obstetrics & General Surgery Plastic Surgery Gynecology Metabolism Dental Gastroenterology Urology General Medicine Psychiatry 8
Slide 9: Health Around the Corner
° Aim bs SINPHAR GROUP Health Around the Corner Bel ey? ey _ ie “ae Fie I AH Life + Health + Technology
Slide 10: Post Pandemic Care
© Aye Bo ee iat roe Post Pandemic Care Rae COVID-19S NER RE RUREE A Ac H IRAN TEM ? o> fle BE RR ie y (ESNDR HPN GEER) FUR ER IB + BB» UHR é val HbR X 7S EAR RETHECOORA | A cee GH SRB feete ARH {a O ; 1c See ‘be | y a 7 \ y SS omin . tip - + FH Life > Health + Technology SE tt~O”CS
Slide 11: International Award Winning Product
International Award Winning Product 11
Slide 12: Potent Plus Soft Capsules
| Sea eee SINPHAR GROUP AG BA Vitamin B1 etc si aad Heart Health aa RTBU S BAMA es jy Fie U2) 3 Exclusive Anti-Fatigue Ingredients With Patents Potent Plus Soft Capsules D Gana FBLA BNR MES 1D BE MET AE) Echinacoside QH D-Ribose in a Git565519™ 5 “lity Mode\ Pe a PEI e tun High gn Enero Levels 5 pat
Slide 13: 經107例人體試驗 證實有感提升保護
經107例人體試驗 證實有感提升保護 *文獻發表中 經國際學術發表文獻證實 具調節免疫、緩解過敏體質雙重作用
Slide 14: Health Foods for Aging Society
Health Foods for Aging Society 三高全照護健康食品系列
Slide 15: Stay healthy, stay beautiful
Stay healthy, stay beautiful SkinPRO® 以 40 年科研經驗 為根基，堅持只給予肌膚最 安心的承諾，挑選安全且穩 定的成分，讓保養回歸理性 與真實。 15
Slide 16: Sinphar Health Park – Sharing Knowledge with the Public
Sinphar Health Park – Sharing Knowledge with the Public 1. Since the opening of the Park, over 150,000 people have visited to understand the manufacturing process of pharmaceuticals and food products. An expansion plan is underway to accommodate the expected over 30,000 visitors for 2026. 2. Located
Slide 17: Production Digitalization
Production Digitalization Production Plan Scheduling Shipping Create Work BI Cockpit Warehouse MRP Order PO Warehouse Receiving ISO/IEC 27001 IQC ISMS QA Warehouse FQC Warehouse Weighing Packaging Picking MM WIP Warehouse MP WIP Warehouse IPQC Cockpit ERP LIMS Production Data APS MES PLC & Equipment
Slide 18: International Markets
International Markets Japan Philippines • Product G, launched in 2020, steady • Product L, applied in 2022 growth • Product G, obtained license in 2023 Thailand Vietnam • Product G, obtained license in 2023 • Product G, expect to obtain license in • Product C, launched 2023, steady 2025 growth • Pro
Slide 19: Growth
Growth Therapeutic Drugs • New registration expected: 5 • Co-develop and manufacture with Japanese pharmaceutical companies and expand ASEAN market • Agent to Japanese products for domestic market • API in-depth development plan (4 products obtained license in recent 2 years; 2 more in development)
Slide 20: Management Philosophy
Management Philosophy 集團員工人均薪資 620,000 600,000 580,000 560,000 540,000 111年前三季 112年前三季 113年前三季 114年前三季 (*內含員工薪資、勞健保、退休金及其他用人費用) 人均薪資 與宜蘭縣政府連續多年共同主辦杏輝宜蘭馬拉松 贊助失智症照護協會 力挺金門長泳 捐贈宜蘭縣政府防疫物資 優良食品製造業者楷模 20
Slide 21: Pipeline
Pipeline SynCoreZ PRE- INNOVATIVE DRUG CLINICAL PHASE | PHASE II PHASE Ill NDA MARKETED SB01 Head & Neck Cancer > RRALARR RAI sssosatn carn $02 Solid Tumor = : Oncology A EndoTAG -1 _ Pancreatic Cancer (PC) a CE*" ina: <a0s hina EndoTAG -1 > . Taiwan Triple Negative Breast Cancer (TNBC) : Dermatolo
Slide 22: Sinphar Group's New Drug Catalog
Refer to Annual Report from Sinphar and Sinphar Group's New Drug Catalog SynCore for more details Memoregain® SB05 PC SB03 Veregen TLCT Plus Pancreatic Cancer Vascular dementia EGW Second Line Treatment:Clinical trial Phase Ⅲ Launched in 20 Obtained license First Line Treatment: NMPA approved; Phase
Slide 23: Memoregain® TLCT Plus Lipucan®
天然資源（原料/提取物） Memoregain® Lipucan® Protygold ® KAZINAKE ® TLCT Plus 天力速康® 杏补宜 ® 杏补宜 ® 天力再生® 茯苓三萜菁萃物 核桃肽 初榨核桃油 (Poria cocos (Walnut oligopeptide) (Walnut Oil) 管花肉蓯蓉提取物 triterpenoids) (Cistanche tubulosa extract) Organic certification EU Ecocert、USDA Organic、China Organic Food Certification Center 23
Slide 24: RD research achievements
RD research achievements Walnut oil won the ITQI and Monde Selection awards in 2023 Walnut oligopeptide won 4 gold and 1 silver international patent invention awards in 2022 Walnut oligopeptide Awards (2024-2025): • HI&FI Health Ingredients Gold Extract Award • Nutrition Intelligence - Application P
Slide 25: Differentiated Marketing
Differentiated Marketing • Taiwan/Mainland China as the core markets for food ingredients, while simultaneously expanding into Northeast Market Asia and ASEAN international markets, with current sales reaching 17 countries worldwide. • To explore new market in the pet industry. • Driven by scientifi
Slide 26: Revenue Overview for the Same Period in Recent Years
Revenue Overview for the Unit：NTD in thousands Same Period in Recent Years Revenue and Gross Margin Revenue by Product Category 2,600,000 44.0% 1,600,000 43.1% 1,400,000 2,500,000 42.0% 2,491,298 1,200,000 2,400,000 40.0% 1,000,000 2,296,239 2,300,000 38.0% 800,000 38.7% 2,214,367 600,000 2,200,000
Slide 27: Cash Flow
Unit: NTD in Thousands Cash Flow Sinphar Group Sinphar Group Sinphar Group Q1~Q3 2025 2024 Q1~Q3 2024 Net Cash generated by 384,033 593,512 405,341 operating activities Net Cash used in investing -135,268 -391,078 -300,957 activities Acquisition of property, plant and equipment -63,513 -179,143 -137
Slide 28: Ratio
Unit: NTD in Thousands Ratio Sinphar Group Sinphar Group Q1~Q3 2025 Q1~Q3 2024 Debt Ratio (%) 41.7 44.6 Current Ratio (%) 221.1 227.0 Accounts Receivable Turnover 4.98 5.12 Accounts Payable Turnover 8.62 7.52 Inventory Turnover 2.60 2.31 Sinphar Group SynCore Q3 2025 Q3 2025 Cash and cash equivalent
Slide 29: Sustainability
Sustainability Product quality and responsibility Talent Regulatory recruitment and compliance retention Labor- Innovation and management Water R&D relations management Supply chain Occupational Carbon Ethical management safety and health emissions management Marketing and Social Energy Corporate la
Slide 30: Sustainability
Sustainability Energy Carbon Water Saving Reduction consumption Energy Intensity* Emission Emission (tons) Intensity* Decrease 30.7627 (Gigajoules/revenue in millions NTD) 3.6047 12% (Metric ton of Co2e/revenue (2024 vs 2023) in millions NTD) 30
Slide 31: Corporate Social Responsibility
Corporate Social Responsibility 1. Host health forum, biotechnology camp. Create a platform to facilitate and cultivate the interaction of medical, academic, and biotechnology professionals 2. Continue to be a sponsor for Breast Cancer Foundation, Spinal Cord Injury Foundation, The Diabetes Associat
Slide 32: Corporate Social Responsibility
Corporate Social Responsibility Supports Education and Sports 1. Donate NTD 5 million over 5 years to Kaohsiung Medical University for students in need of financial assistance 2. The Sinphar Yilan Marathon, co-hosted by Sinphar Group and the Yilan County Government, has gained nationwide recognition
Slide 33: Corporate Social Responsibility
Corporate Social Responsibility 33
Slide 34: “SR RRSS
“SR RRSS SINPHAR GROUP m+ 2 & > HH Life » Health * Technology SS ——
Sinphar Pharmaceutical — 2025 Sinphar Pharmaceutical Investor Conference on 6ix